Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2024 08:30 ET | Source: Elevai Labs Inc.

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical
January 24, 2024 08:30 ET | Source: Elevai Labs Inc.

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
January 17, 2024 08:30 ET | Source: Elevai Labs Inc.

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

ELEVAI Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
January 16, 2024 08:30 ET | Source: Elevai Labs Inc.

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
January 02, 2024 09:15 ET | Source: Elevai Labs Inc.

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
December 11, 2023 09:15 ET | Source: Elevai Labs Inc.

Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023

Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
December 07, 2023 09:41 ET | Source: Elevai Labs Inc.

ELEVAI Labs, Inc. Expands International Distribution into Europe

ELEVAI Labs, Inc. Expands International Distribution into Europe
November 29, 2023 09:00 ET | Source: Elevai Labs Inc.

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences